NFKB1 and alkaline phosphatase measurement: Our results revealed that AS-IV prevented the aggravation of AP by inhibiting the activition of NF-κB and counteracting oxidative stress, which suggests that AS-IV may be effective for the clinical therapy/prevention of AP.